Congenital Hypothyroidism in Newborns: Current Approaches to Diagnosis and Treatment
Congenital hypothyroidism is a deficiency of thyroid hormone present at birth. Clinical signs are often subtle in the neonatal period, although prolonged hormone deficiency can impair brain development. This narrative review examines newborn screening, diagnostic confirmation, and early treatment. Dried blood spot screening based on thyroid-stimulating hormone (TSH) identifies most cases of primary congenital hypothyroidism. An abnormal screening result requires prompt measurement of serum TSH and free thyroxine (FT4), interpreted using age-specific reference intervals. Two diagnostic challenges deserve particular attention. Preterm or critically ill newborns may have a delayed TSH rise, while infants with central hypothyroidism may have low FT4 without a marked TSH elevation. For infants with confirmed primary congenital hypothyroidism, oral levothyroxine is the treatment of choice and should begin as soon as possible, ideally within the first two weeks of life. Thyroid imaging can clarify the underlying cause and should not delay treatment. Follow-up combines serial thyroid function testing with assessment of growth and neurodevelopment. The benefit of newborn screening depends on timely confirmation, prompt treatment, and sustained biochemical control throughout early childhood.
Authors
- Khursanoy Zakirovna Djuraeva
Institutions
- Andijan State Medical Institute (UZ)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24363669
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00